@article{dcf1d6b7fe9940dba295d42a4f01d3f2,
title = "Best practices for screening, testing, diagnosing, and treating patients with hepatitis D (delta) virus based on global expert review and recent guidelines",
keywords = "antiviral therapy, bulevirtide, epidemiology, hepatitis D virus, hepatitis delta, Hepatitis D/diagnosis, Humans, Mass Screening, Hepatitis B Surface Antigens/blood, Antiviral Agents/therapeutic use, Hepatitis Delta Virus/drug effects, Hepatitis D, Chronic/diagnosis, Practice Guidelines as Topic",
author = "Markus Cornberg and Fabien Zoulim and Robert Gish and Jacobson, \{Ira M.\} and Tatyana Kushner and Pietro Lampertico and Mario Rizzetto and Cihan Yurdaydin and Michael Manns",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2025. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",
year = "2025",
month = aug,
doi = "10.1177/13596535251349380",
language = "English",
volume = "30",
journal = "Antiviral Therapy",
issn = "1359-6535",
number = "4",
}